Globus Medical Inc
NYSE:GMED
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of 
Globus Medical Inc (GMED) under the Base Case is USD per share.
Compared with the current market price of 72.14 USD, the stock appears .
The intrinsic value is calculated using the DCF method.
Do our valuations actually work? See backtest results .
What one share is worth in the bear, base and bull cases.
Create a free account · No card needed
Do our valuations actually work? See backtest results .
Intrinsic value next to the price over the past 5 years, and what happened after valuations like today’s.
Create a free account · No card needed
Fundamental Analysis
What Globus Medical Does
Globus Medical makes medical devices for spine and orthopedic surgery. Its main products are implants, surgical instruments, and computer-guided systems that help surgeons treat back, neck, and other bone and joint problems. The company sells these products mainly to hospitals, surgical centers, and spine surgeons.
- Headquarters
- United States of America US
- Employees
- 6 000
- IPO date
- Mar 8, 2012
Globus Medical has no economic moat
Surgeons and hospitals can choose among Globus Medical’s devices and those of many established competitors, while pricing pressure limits the protection its products receive from their name or patents. The evidence does not show that customers are locked in or that Globus can consistently make comparable products more cheaply than rivals.
Read the full moat analysis
Revenue & Expenses Breakdown
Globus Medical Inc
Earnings Waterfall
Globus Medical Inc
What is the Intrinsic Value of one GMED stock?
The intrinsic value for Globus Medical Inc (GMED) under the Base Case is USD.
Is GMED stock undervalued or overvalued?
Compared with the current market price of 72.14 USD, the stock appears .
